ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,433.74
      0.23%
      US Tech 100
      19,086.80
      0.64%
      Dow Jones
      38,647.10
      -0.17%
      Brent Oil
      82.01
      -0.35%
      Bitcoin
      66,668.82
      -2.32%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kiromic BioPharma Inc (KRBP)

      7. Kiromic BioPharma Inc (KRBP) News

      KRBP

      Kiromic BioPharma (KRBP)

      Kiromic BioPharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KRBP
      DateTimeSourceHeadlineSymbolCompany
      06/12/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      06/12/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      06/07/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      06/06/20248:00AMBusiness WireKiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
      06/04/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      05/29/20248:00AMBusiness WireKiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
      05/22/20245:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      05/20/20245:00PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:KRBPKiromic BioPharma Inc
      05/20/20248:00AMBusiness WireKiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial SiteNASDAQ:KRBPKiromic BioPharma Inc
      05/20/20246:29AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:KRBPKiromic BioPharma Inc
      05/17/20244:43PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KRBPKiromic BioPharma Inc
      04/24/20248:08AMBusiness WireKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsNASDAQ:KRBPKiromic BioPharma Inc
      04/19/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      04/10/20244:30PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:KRBPKiromic BioPharma Inc
      04/05/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      04/02/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      04/02/20248:18AMBusiness WireKiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
      03/21/20245:21PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:KRBPKiromic BioPharma Inc
      03/20/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      03/20/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
      03/19/20248:08AMBusiness WireEarly Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
      03/01/20248:08AMBusiness WireKiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
      02/28/20246:30PMBusiness WireKiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thNASDAQ:KRBPKiromic BioPharma Inc
      02/28/20244:09PMGlobeNewswire Inc.Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7thNASDAQ:KRBPKiromic BioPharma Inc
      02/14/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      02/14/20248:08AMBusiness WireResults from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two MonthsNASDAQ:KRBPKiromic BioPharma Inc
      01/29/20247:47AMBusiness WireKiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung CancerNASDAQ:KRBPKiromic BioPharma Inc
      01/11/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
      01/05/20248:08AMBusiness WireKiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
       Showing the most relevant articles for your search:NASDAQ:KRBP

      Your Recent History

      BIT
      UC08P8
      Unicredit Bank
      NASDAQI
      FDSESPR
      FactSet Global Extended ...
      Delayed Upgrade Clock